Published in

Centers for Disease Control and Prevention, Emerging Infectious Diseases, 7(21), p. 1265-1265, 2015

DOI: 10.3201/eid2107.150402

Centers for Disease Control and Prevention, Emerging Infectious Diseases, 7(21), p. 1264-1265, 2015

DOI: 10.3201/eid2107.141448

Centers for Disease Control and Prevention, Emerging Infectious Diseases, 7(20)

DOI: 10.3201/eid2007.140155

Links

Tools

Export citation

Search in Google Scholar

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam

Journal article published in 2014 by Tinh Tt, Nguyen Van Hong, Duong Tt, Alfred Amambua-Ngwa, Tuan Nq, Do Duy Cuong, Nguyen Quang Tuan, Nguyen Thi Huong Giang, Cuong Dd, Nguyen Van Tien, Giang Nt, Ta Thi Tinh, Nguyen Van Dung, Pascal Ringwald, Phuc Bq and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Resistance to artemisinin derivatives, the most potent antimalarial drugs currently used, has emerged in Southeast Asia and threatens to spread to Africa. We report a case of malaria in a man who returned to Vietnam after 3 years in Angola that did not respond to intravenous artesunate and clindamycin or an oral artemisinin-based combination.